San Francisco Sentry Investment Group’s West Pharmaceutical WST Stock Holding History

San Francisco Sentry Investment Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$60K	Sell	167 -1	-0.6%	-$330	0.03%	342
2021 Q1	$47K	Hold	168	–	–	0.02%	387
2020 Q4	$47K	Sell	168 -3	-2%	-$842	0.02%	365
2020 Q3	$47K	Sell	171 -4	-2%	-$1.06K	0.02%	341
2020 Q2	$40K	Hold	175	–	–	0.02%	356
2020 Q1	$27K	Hold	175	–	–	0.02%	355
2019 Q4	$26K	Sell	175 -46	-21%	-$6.7K	0.01%	456
2019 Q3	$31K	Sell	221 -5	-2%	-$688	0.01%	434
2019 Q2	$28K	Hold	226	–	–	0.01%	442
2019 Q1	$25K	Buy	226 +55	+32%	+$5.72K	0.01%	472
2018 Q4	$17K	Buy	+171	New	+$18.6K	0.01%	506

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

San Francisco Sentry Investment Group's WST Position: Q2 2021 in Review

San Francisco Sentry Investment Group reduced its West Pharmaceutical (WST) stake by 0.6% in Q2 2021, selling an estimated $330 and leaving 167 shares worth $60K. The position accounts for 0.03% of the portfolio, ranked #342.

San Francisco Sentry Investment Group first reported a position in WST in Q4 2018 and has held it in 11 quarters since. 640 funds tracked by Wall St. Rank hold WST as of Q2 2021.

San Francisco Sentry Investment Group held 167 shares of West Pharmaceutical worth $60K as of Q2 2021.
San Francisco Sentry Investment Group sold 1 West Pharmaceutical share in Q2 2021, an estimated $330.
West Pharmaceutical made up 0.03% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #342 holding.
San Francisco Sentry Investment Group first reported a position in West Pharmaceutical in Q4 2018 and has held it in 11 quarters since.
640 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.